Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Plus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year